Fact-checked by Grok 2 weeks ago

Sleep study

A sleep study is a test that records physiological activity of the body during sleep to diagnose and evaluate sleep disorders. The most comprehensive type is , a noninvasive, overnight diagnostic procedure that monitors multiple parameters including waves via (EEG), eye movements with (EOG), muscle activity through (EMG), , patterns, blood oxygen levels, and body movements to assess sleep stages, disruptions, and underlying causes. Other types include daytime nap tests, home testing, , and questionnaires. PSG, the gold-standard procedure, helps diagnose conditions like obstructive (OSA), , , and REM sleep behavior disorder by providing detailed data on sleep architecture and respiratory events. Sleep studies are primarily indicated for patients with symptoms such as excessive daytime sleepiness, snoring, witnessed apneas, or insomnia that persists despite behavioral interventions. PSG is typically conducted in a controlled sleep laboratory, while simpler apnea screenings can be done at home, with sensors applied by a technician to monitor at least two hours of sleep for valid results. During the procedure, participants sleep in a comfortable, hotel-like room while a technician observes remotely; additional tests like multiple sleep latency tests may follow to evaluate daytime sleepiness. Risks are minimal, typically limited to mild skin irritation from adhesives, and no radiation or invasive elements are involved. Results from a sleep study are scored according to standards set by the , categorizing sleep into stages (wake, N1-N3 non-REM, and ) and calculating indices like the apnea-hypopnea index (AHI) to quantify severity—where an AHI greater than 30 events per hour indicates severe OSA. Interpretation by a sleep specialist informs treatment options, such as (CPAP) therapy, which may be titrated during a split-night study combining and adjustment. Home-based tests, while less comprehensive, focus on breathing and oxygenation for suspected apnea and have increased accessibility since the early , though in-lab remains essential for complex cases. Overall, sleep studies play a critical role in improving sleep quality and reducing associated risks like by enabling targeted interventions.

Definition and Overview

Definition

A sleep study is a non-invasive diagnostic or research procedure that involves the continuous monitoring and recording of various physiological and behavioral parameters during and to evaluate sleep patterns and identify potential disorders. This test captures data on brain activity, respiratory function, cardiovascular responses, and physical movements, providing a detailed profile of an individual's sleep architecture without requiring surgical intervention or significant discomfort. Key components of a sleep study include the electroencephalogram (EEG), which records brain wave patterns to determine sleep stages; the electromyogram (EMG), which measures and activity, particularly in the and legs; and the electrooculogram (EOG), which tracks eye movements to distinguish between rapid eye movement (REM) and non-REM sleep phases. Additional vital signs monitored encompass airflow through the nose and mouth, respiratory effort via chest and abdominal sensors, through electrocardiogram (ECG), and blood oxygen saturation using , all integrated to offer a comprehensive view of sleep . Unlike casual sleep tracking via consumer wearables or apps, which provide limited, self-reported or approximate , sleep studies emphasize structured, overnight or timed sessions in controlled environments—such as sleep laboratories or home setups with professional equipment—for accuracy and clinical reliability. The primary objectives are to diagnose sleep disorders like or apnea, assess overall sleep quality and efficiency, and investigate underlying sleep patterns for research or therapeutic purposes.

Historical Development

The foundations of modern sleep studies were laid in the early through pioneering physiological research. , often regarded as the father of sleep research, established the world's first dedicated sleep laboratory at the in the 1920s, where he began systematic investigations into sleep regulation and patterns. His early work focused on sleep-wake s, including observations of ultradian rhythms in infants and adults, laying the groundwork for understanding sleep architecture. In 1938, Kleitman conducted a notable in Mammoth Cave, , with graduate student Bruce Richardson, isolating themselves in darkness for a month; attempting to follow a 28-hour schedule to study circadian flexibility, Kleitman maintained a cycle close to 24 hours, while Richardson adapted to approximately 28 hours, offering early evidence of individual differences in the human internal clock. A major breakthrough came in 1953 when Kleitman, collaborating with graduate student Eugene Aserinsky, discovered rapid eye movement (REM) sleep. Using (EOG) to monitor eye movements alongside (EEG), they identified recurrent periods of rapid, jerky eye motility during sleep, associated with low-voltage EEG patterns and muscle atonia, which were later linked to dreaming. This finding, published in Science, revolutionized sleep research by revealing sleep as an active process with distinct stages rather than uniform rest. The development of (PSG) in the and built on these advances, integrating multiple physiological recordings for comprehensive sleep monitoring. EEG, first recorded in humans by in 1924, was adapted for sleep studies in the 1930s by Alfred Loomis and colleagues, who described initial sleep stages based on brain wave patterns. By the , William Dement and Kleitman refined sleep staging criteria using EEG, EOG, and (EMG), enabling the identification of non-REM and REM phases. The first clinical sleep disorders center opened at in 1964, focusing on with EEG-based monitoring. In the , PSG expanded to diagnose and other disorders, with Christian Guilleminault's work at Stanford demonstrating syndrome through combined respiratory and EEG recordings, marking PSG's transition from research to clinical tool. Standardization efforts accelerated in the late 20th century to ensure consistency in sleep study interpretation. The seminal 1968 manual by Allan Rechtschaffen and Anthony Kales established rules for scoring sleep stages using 20- or 30-second epochs based on EEG, EOG, and EMG criteria, dividing sleep into stages 1-4 (non-REM) and REM; this framework became the global standard for decades. In 1992, the American Sleep Disorders Association (ASDA, predecessor to the AASM) published scoring rules for EEG arousals, defining them as abrupt shifts in EEG frequency lasting 3-15 seconds during non-REM sleep, which improved detection of sleep fragmentation in disorders like apnea. The American Academy of Sleep Medicine (AASM), formed in 1999, released its comprehensive Manual for the Scoring of Sleep and Associated Events in 2007, updating staging to three non-REM stages (N1-N3) and incorporating respiratory, cardiac, and movement events; this was revised in 2017 to refine criteria based on new evidence, such as adjustments to arousal scoring with frontal EEG leads, with Version 3 released in 2023 providing further updates to scoring rules, including refinements for respiratory events and pediatric applications. Key milestones in the and reflected a shift toward and technological integration. The saw the emergence of home sleep apnea testing (HSAT) with portable devices measuring airflow, oxygen saturation, and effort, driven by limited lab capacity and early validation studies; a 1994 ASDA review endorsed limited use for uncomplicated cases, paving the way for broader adoption. By the , digital tools transformed sleep studies, with computerized PSG systems replacing analog reel-to-reel recordings for automated scoring and data analysis, while —wrist-worn accelerometers tracking movement—gained traction for long-term ambulatory monitoring, enhancing research on circadian and sleep-wake patterns.

Purposes and Indications

Clinical Diagnostic Uses

Sleep studies are primarily indicated in clinical settings to diagnose a range of sleep disorders, including (OSA), (CSA), , , (RLS), and (PLMD). For OSA, (PSG) is the standard diagnostic tool for patients presenting with symptoms suggestive of sleep-disordered breathing, confirming the presence and severity of airway obstructions during sleep. In cases of suspected CSA, PSG helps differentiate central from obstructive events, particularly in patients with underlying conditions like . diagnosis typically requires PSG followed by a (MSLT) to assess and rapid entry into REM sleep. For , sleep studies are not routinely recommended but may be used when comorbid disorders, such as sleep apnea, are suspected to contribute to sleep maintenance issues. RLS evaluation generally relies on clinical history, though PSG can clarify associated PLMD if sleep fragmentation is prominent. PLMD is diagnosed via PSG to quantify periodic limb movements and their impact on sleep continuity when accompanied by or daytime fatigue. Common symptom triggers prompting referral for a sleep study include , loud , witnessed apneas or gasping during sleep, and unexplained fatigue or tiredness that impairs daily functioning. These symptoms often indicate underlying disruptions in sleep architecture, such as those seen in OSA or , and warrant objective testing to rule out treatable causes beyond simple . In treatment planning, sleep studies play a crucial role by quantifying disorder severity to guide interventions like (CPAP) therapy or surgical options. For instance, the Apnea-Hypopnea Index (AHI), calculated as the number of apneas plus hypopneas divided by total hours of , categorizes OSA severity (mild: 5-15 events/hour; moderate: 15-30; severe: >30) and informs CPAP titration to achieve therapeutic levels below 5 events/hour. This objective measurement ensures personalized management, reducing risks like cardiovascular complications associated with untreated OSA. The (AASM) provides evidence-based guidelines recommending PSG for adults with suspected OSA based on clinical symptoms, as a standard practice supported by Level I-II evidence from diagnostic studies. For , AASM endorses PSG plus MSLT when excessive sleepiness persists despite adequate prior sleep, with diagnostic criteria including mean sleep latency ≤8 minutes and ≥2 sleep-onset REM periods. These recommendations emphasize sleep studies' utility in confirming diagnoses where subjective reports alone are insufficient, prioritizing high-impact, widely adopted protocols.

Research and Other Applications

Sleep studies play a crucial role in investigating sleep architecture across diverse populations, particularly in understanding how environmental and lifestyle factors disrupt normal sleep patterns. For instance, has been employed to examine alterations in sleep stages among night shift workers, revealing increased awakenings and sleep fragmentation compared to day workers, which contributes to and impaired cognitive function. Similarly, research using has demonstrated that induces fragmented sleep and delayed sleep onset. Studies on disorders, such as delayed sleep phase syndrome, utilize and to map phase shifts, showing desynchronized rhythms that persist beyond acute disruptions. Additionally, pharmacological interventions are evaluated through controlled sleep studies to assess their impact on sleep continuity; for example, benzodiazepines have been found to increase total sleep time but reduce stages in healthy volunteers. Longitudinal research employing repeated has illuminated age-related changes in , such as progressive fragmentation and decreased sleep efficiency in older adults, linking these shifts to heightened risks of cognitive decline over decades. In extreme environments, NASA-funded analog studies simulate microgravity conditions using protocols combined with , which have identified shortened durations and elevated arousal indices among participants, informing countermeasures for during long-duration missions. Beyond pure scientific inquiry, sleep studies inform occupational health assessments for high-risk professions. Objective monitoring via and in pilots has uncovered irregular sleep-wake cycles leading to , prompting fatigue risk management systems in . For commercial drivers, similar evaluations reveal heightened apnea events during rest periods, correlating with increased crash risks and supporting regulatory screening protocols. In forensic contexts, video-polysomnography aids in evaluating sleep-related behaviors like parasomnias, where abnormal EEG patterns during confirm involuntary actions, such as or sexual behavior, exonerating individuals in legal proceedings. For athletes, sleep tracking through wearables and optimizes ; extending sleep to 10 hours nightly has improved sprint times by approximately 4% and shooting accuracy by 9-10% (free throws and 3-point field goals) in basketball players. Ethical considerations in sleep research emphasize robust protocols, which differ from clinical settings by requiring detailed disclosures of experimental procedures, potential psychological distress from paradigms, and the right to withdraw without affecting future care, ensuring participant autonomy while minimizing in longitudinal or invasive studies.

Types of Sleep Studies

(PSG)

Polysomnography (PSG), also known as a sleep study, is a comprehensive, laboratory-based diagnostic that simultaneously records multiple physiological parameters during an overnight period to evaluate and detect abnormalities such as sleep-disordered . Performed in an attended sleep laboratory, PSG involves attaching electrodes and sensors to the patient's body to monitor brain activity, eye movements, , heart rhythm, patterns, oxygen levels, and other variables. The standard setup adheres to guidelines from the (AASM), which recommend at least seven channels: (EEG) for sleep staging (typically two central and two occipital derivations with references), (EOG) for eye movements (one horizontal and one vertical channel), (EMG) for submental and limb muscle activity, (ECG), airflow via thermistor and nasal pressure transducer, respiratory effort through thoracic and abdominal belts, and for . Additional monitoring may include video recording, microphones, and body position sensors to provide contextual data. The for typically begins with patient preparation in the evening, including sensor application by a certified sleep technologist, followed by a period of adaptation in a quiet, darkened room mimicking a environment. Recording starts at the patient's habitual with "lights out," continuing for 6 to 8 hours or until morning awakening, aiming to capture at least two full sleep cycles and a minimum of 4 hours of technically adequate data. In cases of suspected moderate-to-severe (OSA), a split-night may be employed, dedicating the first 2 hours to diagnosis and the remainder to (CPAP) titration if the apnea-hypopnea index (AHI) exceeds 20 to 30 events per hour. This attended format ensures real-time adjustments and artifact minimization, with data scored according to AASM standards for sleep stages, respiratory events, and arousals. PSG specifically measures respiratory disturbances central to disorders like OSA, defining apneas as a ≥90% reduction in airflow for ≥10 seconds, classified as obstructive (with continued respiratory effort) or central (without effort). Hypopneas are identified as a ≥30% airflow reduction for ≥10 seconds accompanied by ≥3% oxygen desaturation or an , while arousals are scored as abrupt shifts in EEG frequency (e.g., to alpha or theta waves) lasting ≥3 seconds following ≥10 seconds of stable sleep. These metrics enable quantification of the AHI and other indices to assess severity and guide . PSG serves as the gold standard for diagnosing OSA and complex sleep disorders, offering high diagnostic accuracy (88-98% for AHI ≥5) and the ability to detect coexisting conditions like . However, its limitations include substantial costs, patient inconvenience from the unfamiliar lab setting (potentially causing a "first-night effect" that alters sleep), and limited accessibility due to resource demands.

Daytime Nap Tests (MSLT and MWT)

Daytime nap tests, including the (MSLT) and Maintenance of Wakefulness Test (MWT), are objective assessments used to evaluate and alertness, typically performed the day following an overnight (PSG) study. These tests employ (EEG) monitoring to measure sleep propensity or resistance in controlled conditions, aiding in the of disorders like narcolepsy and in assessing fitness for safety-sensitive occupations. Standardized protocols from the (AASM) ensure consistency, with both tests conducted in a sleep under dim lighting and minimal stimulation. The MSLT quantifies sleep tendency by recording the time to sleep onset during scheduled naps, providing a measure of physiologic sleepiness. Developed in the late 1970s by Mary A. Carskadon and at , it was formalized as a standard tool in the 1980s to assess daytime beyond subjective reports. The protocol involves four to five nap opportunities, each lasting up to 20 minutes, spaced two hours apart, beginning 1.5 to 3 hours after the end of the preceding nocturnal . Patients are instructed to lie quietly in a darkened room and attempt to fall asleep, with EEG, electrooculogram, and chin electromyogram recorded to detect sleep onset, defined as the first epoch of sleep (typically stage N1). If sleep occurs, the nap ends after 20 minutes or upon arousal; if no sleep after 20 minutes, the nap terminates. Interpretation of MSLT results focuses on mean sleep latency, calculated as the average time to sleep onset across valid naps (excluding any nap with no sleep after 20 minutes, where latency is scored as 20 minutes). A mean sleep latency of 8 minutes or less indicates , while values above 10 minutes suggest normal alertness. For diagnosis, the test also evaluates sleep-onset REM periods (SOREMPs), defined as REM sleep within 15 minutes of sleep onset; the presence of two or more SOREMPs, combined with a mean sleep latency of 8 minutes or less, supports the diagnosis per AASM and criteria. SOREMPs reflect disrupted REM sleep regulation characteristic of , though they can occasionally occur in other conditions like if untreated. The MSLT is particularly indicated for confirming in patients with symptoms of excessive sleepiness and or other features. In contrast, the MWT assesses the ability to maintain wakefulness under soporific conditions, emphasizing resistance to sleep rather than propensity to sleep. First described in by Mitler et al. as a variant of the MSLT, with normative studies published in by Khalil Doghramji and colleagues, it evaluates alertness in monotonous settings relevant to occupational demands. The standard protocol consists of four 40-minute trials, spaced two hours apart, in a semi-upright position in a dimly lit room with no stimuli; patients are asked to resist sleep while EEG monitors for the onset of sleep. Each trial ends at 40 minutes if no sleep occurs, upon three consecutive 30-second epochs of sleep, or after a 90-second recovery period following sleep onset. MWT results are interpreted via mean sleep latency across the four trials, with longer latencies indicating better wakefulness maintenance. A mean sleep latency greater than 20 minutes is associated with adequate , while values below 8 minutes signify sleepiness; latencies between 8 and 40 minutes represent a gray zone of intermediate risk. The test is recommended by AASM for evaluating efficacy in hypersomnolence disorders and for determining occupational fitness, such as in commercial drivers or pilots where impaired poses safety risks. Unlike the MSLT, the MWT does not routinely score SOREMPs, as its focus is on wake maintenance rather than sleep architecture.

Home Sleep Apnea Testing (HSAT)

Home sleep apnea testing (HSAT), also known as home sleep testing, involves the use of portable monitoring devices to diagnose (OSA) in a patient's . These devices focus on detecting respiratory disturbances during sleep without the need for attendance, making them a convenient alternative to traditional for specific cases. HSAT is primarily indicated for adults with a high pretest probability of moderate-to-severe OSA and no significant comorbidities, such as or . According to the (AASM) classification, HSAT devices are categorized as Type II, III, or IV based on the number and type of physiological channels recorded. Type II devices provide comprehensive unattended with at least seven channels, including (EEG), (EOG), (EMG), (ECG), , respiratory effort, and , though they are less commonly used due to complexity. Type III devices, the most prevalent for HSAT, utilize 4-7 channels focused on cardiorespiratory parameters such as nasal pressure or , thoracic and abdominal effort (via respiratory inductance plethysmography belts), , and sometimes or body position. Type IV devices employ 1-3 channels, typically oximetry alone or combined with or peripheral arterial tonometry, offering simplicity but reduced diagnostic depth. The procedure for HSAT is straightforward and patient-centered: a qualified sleep or instructs the patient on self-application of the device, which is worn overnight in the home for a single night, capturing at least four hours of valid data. Signals are recorded unattended, with raw data later reviewed and manually scored by a board-certified physician to ensure technical adequacy and interpret results. This approach is suitable for evaluating uncomplicated suspected OSA, where symptoms like habitual , witnessed apneas, and are present without complicating factors. Key advantages of HSAT include enhanced patient convenience in a familiar sleep setting, which may promote more natural sleep patterns, reduced costs compared to in-laboratory studies (often 50-70% lower), and improved accessibility for those in remote areas or with scheduling constraints. However, limitations are notable: HSAT cannot stage sleep due to the absence of EEG, potentially underestimating the apnea-hypopnea index (AHI) by basing calculations on total recording time rather than actual sleep time (yielding a respiratory event index, or REI); it also fails to detect non-respiratory sleep disorders such as (PLMD) or seizures, and results may be inconclusive in up to 15-20% of cases due to technical failures like poor sensor contact. For validation, HSAT calculates the REI similarly to PSG's AHI by counting apneas and hypopneas per hour but is less comprehensive, lacking detection or sleep architecture analysis; it compares favorably to laboratory PSG in accuracy for moderate-to-severe OSA, with a positive predictive value exceeding 90% in patients with high pretest probability. In such cases, an REI ≥30 events per hour confirms severe OSA with high reliability, though negative or borderline results often necessitate confirmatory PSG.

Actigraphy and Wearables

is a non-invasive method that employs wrist-worn accelerometers to monitor physical movement and, in some devices, light exposure, thereby estimating sleep-wake patterns over extended periods such as days or weeks. These devices, typically and resembling a wristwatch, record activity levels continuously, with algorithms interpreting periods of low movement as likely and high movement as . Key parameters derived include total sleep time, sleep efficiency (the ratio of time asleep to time in bed), and sleep fragmentation (the frequency of transitions between sleep and wake states), providing objective data on habitual sleep patterns without the need for laboratory settings. Consumer wearables, such as and models, extend principles by integrating accelerometers with additional sensors like photoplethysmography for (HRV) monitoring, enabling approximate sleep staging into light, deep, and phases. These devices use algorithms to analyze combined motion and physiological data, offering user-friendly interfaces for tracking metrics via apps. However, their staging accuracy varies, with overall sleep-wake detection reaching 86-88% in validation studies, though deep and sleep identification remains less precise due to reliance on indirect proxies rather than direct neural measures. Actigraphy and wearables find primary applications in assessing sleep-wake disorders, monitoring characteristics, and evaluating pediatric patterns, where long-term monitoring reveals disruptions not captured by single-night tests. The recommends for characterizing in these contexts, particularly in children with suspected circadian issues, as it provides reliable estimates of timing and duration over multiple nights. Validation against (), the gold standard, shows strong correlations for total time (0.85-0.95) and efficiency in healthy and disordered populations, though accuracy drops for detailed architecture like REM detection. Limitations include overestimation of during motionless wakefulness and underestimation of subtle arousals, restricting their use for comprehensive staging. Recent advances as of 2025 include FDA clearances for wearable devices in (OSA) screening, such as Apple's sleep apnea detection feature on compatible watches and the Happy Ring for OSA and diagnosis, enhancing accessibility for at-home monitoring. These developments build on actigraphy's foundation, incorporating refined algorithms and multi-sensor fusion to improve clinical utility while maintaining the method's emphasis on longitudinal, unobtrusive assessment.

Sleep Questionnaires and Diaries

Sleep questionnaires and diaries serve as subjective, self-reported tools to evaluate sleep patterns, quality, and daytime functioning without the need for physiological monitoring. These instruments are widely used in clinical and research settings to capture patients' perceptions of their sleep, providing insights into habits, disturbances, and impairments that may indicate disorders such as or . The Epworth Sleepiness Scale (ESS) is a brief questionnaire designed to measure general daytime sleepiness by asking respondents to rate, on a 0-3 scale across eight scenarios, their likelihood of dozing off, yielding a total score from 0 to 24; scores above 10 suggest excessive daytime sleepiness. Developed in 1991, the ESS has demonstrated good internal consistency (Cronbach's alpha ≈ 0.88) and test-retest reliability (r ≈ 0.82) in various populations. The (PSQI) assesses overall sleep quality over the past month through 19 self-rated items and 5 caregiver-rated items, grouped into seven components that produce a global score from 0 to 21; a score greater than 5 indicates poor sleep quality. Introduced in 1989, the PSQI exhibits strong reliability (test-retest r = 0.87) and validity, particularly in distinguishing good sleepers from those with disturbances in psychiatric and medical populations. Sleep diaries, such as the Consensus Sleep Diary (CSD), involve daily logging of bedtime, , wake times after sleep onset, terminal wakefulness, total sleep time, and subjective quality ratings, typically over 1-2 weeks. These diaries show moderate to high reliability (e.g., test-retest correlations >0.70 for key metrics) and validity when compared to objective measures like for assessing symptoms. Administration of these tools is straightforward, with patients completing questionnaires like the or PSQI in 5-10 minutes during a clinic visit and maintaining diaries at home for 1-2 weeks to track patterns; they are often used for initial screening or to complement objective tests such as . Validation studies confirm their high reliability for diagnosing (sensitivity >80%) and , with the showing moderate correlations (r = 0.4-0.6) to objective measures like the . As cost-effective, non-invasive first-line assessments, sleep questionnaires and diaries guide clinicians in determining the need for more resource-intensive objective studies, enhancing diagnostic efficiency in .

Procedures and Preparation

Patient Preparation

Patients preparing for a sleep study are advised to maintain their usual schedule in the days leading up to the test to reflect typical patterns and ensure accurate results. They should avoid after noon and for at least 24 hours prior, as these substances can disrupt architecture and interfere with diagnostic measurements. Napping during the day of the study is also discouraged to promote natural onset. Patients are encouraged to bring comfortable sleepwear, personal toiletries for their routine, and any prescribed medications, while consulting their healthcare provider about continuing regular medications. For in-laboratory studies such as , patients should arrive 1 to 2 hours early in the evening to allow time for sensor application by a . A shower or beforehand is recommended, but lotions, oils, hair products, or makeup should be avoided, as they can prevent electrodes from adhering properly to the skin and scalp. Patients must inform staff of any allergies to adhesives or sensitivities that could affect sensor placement. Preparation for home sleep apnea testing (HSAT) emphasizes familiarity with the device to minimize setup errors. Patients receive instructions and may practice applying sensors, such as nasal cannulas or oximeters, using provided tutorials or videos before the test night. The testing environment should be quiet and similar to usual sleeping conditions, with the study conducted during normal bedtime hours to capture representative data. As with lab studies, and avoidance applies, and light meals are suggested to avoid discomfort. Special considerations apply for pediatric patients or those with anxiety. For children, parents should discuss the procedure in advance, potentially using lab tours or home practice with mock sensors to reduce fear and separation anxiety; allowing a quiet in the room during setup can further promote comfort. In cases of significant anxiety for any patient, relaxation techniques such as deep breathing may be recommended. Adequate prior sleep, documented via diary, is particularly emphasized for children to meet age-specific needs.

Conducting the Study

In laboratory-based sleep studies, such as (), a registered polysomnographic technologist attaches more than 20 sensors to the patient's body, including electrodes for (), (), (), and additional monitors for airflow, respiratory effort, and . These sensors are calibrated prior to the start of recording to ensure accurate data capture, after which the technologist retreats to an adjacent equipped with video cameras and audio systems for continuous, non-intrusive monitoring of the patient's sleep behaviors and physiological signals. The patient is instructed to follow their natural sleep routine, with lights dimmed and environmental noise minimized to facilitate undisturbed rest, while any spontaneous arousals or movements are documented in real time by the technologist. For home-based studies, such as home testing (HSAT), patients self-apply a simplified set of sensors, typically including a for airflow, belts for respiratory effort, and a pulse oximeter for oxygen levels, following provided instructions or video guides. The device features automated start and stop functions, initiating recording upon activation in the evening and concluding after the patient's habitual duration, often around 6-8 hours. Common issues, such as loose sensors or poor connections, may require patient , such as readjusting placements or contacting support if appears compromised upon review. The duration of the study varies by type; overnight PSG sessions typically last 8 hours to capture a full aligned with the patient's habitual , while daytime nap tests like the (MSLT) involve 4-5 scheduled 20-minute opportunities spaced 2 hours apart, with the full procedure spanning approximately 7-9 hours following an overnight PSG. Patients in both lab and home settings experience a controlled environment designed to mimic natural conditions, with dimmed lighting and a quiet atmosphere to promote relaxation; in labs, any necessary interventions, such as repositioning sensors, are performed discreetly to minimize disruptions, and all arousals—whether self-reported or observed—are noted to contextualize the data without altering the process.

Equipment and Data Collection

Sleep studies employ a variety of sensors to capture physiological signals during , ensuring comprehensive monitoring of sleep-related processes. Electroencephalogram (EEG) electrodes are affixed to the to record brain wave activity, including (8-13 Hz) associated with relaxed wakefulness, theta waves (4-8 Hz) prominent in light sleep, delta waves (0.5-4 Hz) characteristic of , beta waves (>13 Hz) during , and sleep spindles (bursts of 11-16 Hz activity) indicative of stage 2 non-REM sleep. Thermistors, placed near the nostrils or mouth, measure nasal and oral airflow to detect breathing patterns and apneas. Strain gauges or inductive bands encircle the chest and abdomen to monitor respiratory effort by tracking thoracic and abdominal movements. A pulse oximeter, typically clipped to a finger or , continuously measures peripheral (SpO2) and pulse rate to identify desaturations. Recording systems in sleep studies utilize digital polygraphs or amplifiers to acquire and store multichannel data, with a standard sampling rate of at least 200 Hz to capture high-frequency signals like EEG without aliasing. These systems often include synchronized infrared video recording to correlate physiological data with observable behaviors, such as body position or movements. In laboratory settings, wired connections predominate for polysomnography (PSG), while modern home sleep apnea testing (HSAT) devices incorporate wireless transmission for portability. The collected data consist of continuous analog waveforms across multiple channels; standard PSG setups typically involve 8-16 channels, encompassing EEG (2-8 derivations), electrooculogram (EOG), electromyogram (EMG), electrocardiogram (ECG), airflow, respiratory effort, and oximetry. These waveforms are digitized in , enabling subsequent processing while preserving for accurate monitoring. Quality control during data collection focuses on minimizing artifacts, such as those from patient movement or electrode displacement, through real-time monitoring and automated rejection algorithms that flag irregular signals for technician intervention. Impedance checks on electrodes ensure signal integrity, and environmental controls reduce external noise, maintaining data reliability throughout the study.

Analysis and Interpretation

Sleep Staging and Scoring

Sleep staging involves classifying sleep into distinct stages based on physiological signals recorded during (PSG), primarily using (EEG), (EOG), and (EMG). The (AASM) provides standardized rules for this process, dividing sleep into non-rapid eye movement (NREM) stages N1, N2, and N3, (REM) sleep, and . These rules ensure consistency in identifying normal sleep architecture across studies. According to AASM guidelines, sleep data is scored in 30-second epochs, with each epoch assigned to one stage based on predominant features. Wake is characterized by alpha rhythm (8-13 Hz) in the EEG, rapid eye movements in EOG, and high EMG tone in the chin musculature. Stage N1, the transition to light sleep, features theta waves (4-7 Hz) in the EEG, slow eye movements in EOG, and moderate EMG tone. Stage N2 includes sleep spindles (11-16 Hz bursts) and K-complexes (high-amplitude negative-positive waves) in the EEG, with no eye movements and reduced EMG. Stage N3, or slow-wave sleep, requires slow-wave activity (0.5-2 Hz, amplitude ≥75 μV) occupying at least 20% of the epoch, accompanied by low EMG and absence of eye movements. REM sleep is identified by low-amplitude mixed-frequency EEG (often sawtooth waves), rapid eye movements in EOG, and minimal EMG tone, resembling wake but with atonic muscle activity. Manual scoring remains the gold standard, performed by registered sleep technologists who visually review raw EEG, EOG, and EMG signals by to apply AASM criteria. This process demands expertise to discern subtle waveform patterns and artifacts, ensuring accurate stage assignment. Automated scoring software, using algorithms like models trained on PSG datasets, can preprocess data and suggest stage classifications to expedite review; however, human verification is mandatory due to potential errors in ambiguous or atypical patterns, as automated systems require oversight for clinical reliability. Key metrics derived from staging quantify sleep architecture. Total sleep time (TST) is the cumulative duration of all sleep epochs, excluding wake periods. Sleep efficiency is calculated as (TST / total recording time in bed) × 100%, with values above 85% considered normal in healthy adults. Stage percentages relative to TST provide insight into sleep composition; for example, typical distributions in young adults include approximately 5% N1, 45-55% N2, 15-25% N3, and 20-25% REM. Inter-scorer reliability for manual staging is assessed using statistic, which measures agreement beyond chance. Meta-analyses report overall kappa values of 0.76 for AASM-based scoring (95% CI: 0.71–0.81), indicating substantial agreement among trained scorers, with stage-specific values of Wake 0.70, N1 0.24, N2 0.57, N3 0.57, and 0.69. These metrics underscore the robustness of standardized rules while highlighting the need for ongoing training to minimize variability, particularly for challenging stages like N1.

Identifying Abnormalities

In polysomnography (PSG), abnormalities are identified by analyzing physiological signals for deviations that indicate sleep disorders, building on sleep staging to pinpoint pathological events within specific sleep phases. Apnea events are scored when there is a ≥90% reduction in airflow lasting ≥10 seconds, distinguished as obstructive if respiratory effort persists despite the airflow cessation. Hypopnea events are defined by a ≥30% reduction in airflow for ≥10 seconds, accompanied by either a ≥3% oxygen desaturation from pre-event baseline or an associated arousal. Other key markers include frequent arousals linked to increased respiratory effort without significant airflow reduction, exceeding 5 per hour, which signal (UARS). Periodic limb movements in sleep (PLMS) are flagged when leg movements occur at a rate >15 per hour, characterized by stereotyped extensions or flexions of the big toe and ankle lasting 0.5-10 seconds with intervals of 5-90 seconds, often indicating (PLMD) if associated with clinical symptoms. In the (MSLT), sleep-onset REM periods (SOREMPs)—defined as REM sleep occurring within 15 minutes of sleep onset—appearing in ≥2 naps, alongside a mean sleep latency ≤8 minutes, are diagnostic markers for . Quantitative metrics provide severity context; the apnea-hypopnea index (AHI), calculated as the total number of apneas and hypopneas per hour of , categorizes as mild (5-15 events/hour), moderate (15-30 events/hour), or severe (>30 events/hour). The (RDI) extends this by incorporating respiratory effort-related arousals (RERAs) alongside apneas and hypopneas, yielding a broader measure of respiratory instability per hour of . Data integration often involves correlating physiological signals with video recordings to confirm behavioral abnormalities, such as , where rhythmic masticatory muscle activity or grinding sounds align with jaw movements observed on video.

Reporting Results and Follow-Up

The reporting of sleep study results involves a structured format designed to ensure clarity and utility for clinical decision-making. A typical report begins with administrative and patient demographic information, including age, sex, (BMI), , medications, and the reason for referral, followed by details on technical adequacy such as recording duration and equipment used. Core sections summarize key sleep metrics like total sleep time, sleep efficiency, arousal index, and REM latency; event counts including the apnea-hypopnea index (AHI) and periodic limb movement index; and visual representations such as hypnograms illustrating sleep stage distributions and waveforms depicting respiratory or cardiac events. These elements are interpreted by a board-certified sleep physician, who integrates findings to diagnose conditions like (OSA) and assess severity. Results are delivered promptly to facilitate timely care, with a written report sent to the referring typically within a few days to two weeks after the study, depending on the facility's protocols. Patients receive a detailed discussion of the findings during a follow-up visit with the sleep specialist, where the report's implications are explained in accessible terms, addressing any detected abnormalities such as respiratory events or sleep fragmentation. This communication ensures alignment between diagnostic outcomes and treatment planning. Recommendations in the report are tailored to the results, prioritizing evidence-based interventions; for instance, a high AHI indicating moderate to severe OSA often prompts referral for a (CPAP) titration study to determine optimal pressure settings, while milder cases may suggest lifestyle modifications like or positional therapy. Additional guidance might include surgical options, oral appliances, or further testing for comorbidities, with emphasis on to promote adherence. Quality assurance in reporting is maintained through standardized scoring guidelines and interscorer reliability measures, with meta-analyses indicating percentage agreement rates ranging from 61% to 92% across sleep stages among trained technologists, though stage identification shows lower consistency around 20-38%. For complex cases involving ambiguous epochs or multiple abnormalities, double-scoring by independent reviewers is employed to minimize discrepancies and ensure diagnostic accuracy below accepted error thresholds of 15%. Accredited facilities adhere to these practices as part of ongoing proficiency programs.

Applications

In Sleep Medicine

In sleep medicine, sleep studies form a cornerstone of the diagnostic pathway for identifying and managing sleep disorders, particularly (OSA). The process typically begins with screening using validated questionnaires, such as the or STOP-BANG, to assess symptoms like and , followed by a focused clinical evaluation by a sleep specialist. If suspicion of OSA is high, confirmatory testing proceeds with (PSG) as the gold standard, which records multiple physiological parameters including brain waves, , and to quantify apnea-hypopnea index (AHI). For moderate-to-severe cases, studies are then conducted to determine optimal settings for therapies like (CPAP) or oral appliances, ensuring effective airway support during sleep. Treatment monitoring often involves repeat sleep studies to evaluate therapeutic efficacy and adjust interventions as needed. For instance, post-CPAP titration PSG verifies adherence and AHI reduction, while follow-up studies after surgical interventions, such as uvulopalatopharyngoplasty or hypoglossal nerve stimulation, assess improvements in respiratory events; one meta-analysis reported average AHI reductions of 50% or more in successful bariatric surgery cases for obese OSA patients. These repeat assessments are particularly indicated after significant weight changes, as weight loss can alter sleep architecture and reduce AHI by up to 50% in some cohorts. Adaptations in sleep studies are tailored to specific populations to address unique physiological needs. In , PSG often incorporates expanded (EEG) channels—up to 16 or more—to differentiate sleep-disordered breathing from nocturnal seizures, given the higher prevalence of comorbid in children with OSA. For , studies emphasize metrics of sleep fragmentation, such as arousal index and awakenings, as aging naturally increases lighter sleep stages and disruptions, exacerbating conditions like or OSA. In bariatric patients, pre- and post-weight loss PSG tracks changes in AHI and oxygen desaturation, informing surgical candidacy and long-term management. Effective integration of sleep studies into clinical care yields measurable health outcomes, notably in OSA management. Adherent CPAP use, guided by diagnostic and titration studies, has been associated with a 20-30% reduction in cardiovascular event risk, including and , based on meta-analyses of observational and randomized data. These benefits underscore the role of sleep studies in preventing comorbidities, improving survival rates, and enhancing across diverse patient groups.

In Psychology and Behavioral Science

Sleep studies, particularly (PSG), play a crucial role in and behavioral science by elucidating how sleep architecture influences cognitive processes and emotional regulation. These investigations reveal that distinct sleep stages contribute to , with (REM) sleep being essential for , such as skill acquisition and tasks. In mood disorders like , PSG often identifies reduced (SWS), which correlates with persistent negative affect and impaired emotional processing, highlighting sleep's bidirectional ties to psychological . In behavioral applications, sleep studies inform the assessment of conditions involving excessive daytime sleepiness, such as in attention-deficit/hyperactivity disorder (ADHD), where the (MSLT) objectively measures shortened sleep onset times, distinguishing behavioral sleepiness from other causes. Research also underscores insomnia's bidirectional relationship with anxiety disorders, with comorbidity rates approaching 50%, where sleep disturbances exacerbate worry cycles and vice versa, as evidenced by longitudinal studies tracking symptom progression. Key research insights from sleep deprivation experiments demonstrate significant impairments in , including and , even after a single night of total sleep loss, as shown in controlled tasks assessing prefrontal cortex-dependent performance. Chronotype assessments, often via validated questionnaires, enable tailoring psychological therapies to individual circadian preferences, optimizing intervention timing for better adherence and outcomes in behavioral sleep management. Interventions like (CBT-I) rely heavily on sleep diary data to personalize strategies, such as and sleep restriction, which track patterns to reshape maladaptive sleep behaviors and improve long-term . These diary-informed approaches, integrated with objective measures from studies, enhance treatment efficacy by addressing the cognitive distortions that perpetuate in behavioral contexts.

Professionals and Facilities

Sleep Technologists and Staff

Sleep technologists are allied health professionals who play a critical role in the execution of sleep studies, particularly . Registered Sleep Technologists (RST) hold a awarded by the American Board of Sleep Medicine (ABSM), established in 2011 to certify competency in technology practices. Their primary duties include applying sensors and electrodes to patients for monitoring physiological signals, overseeing the study overnight to ensure data integrity, and performing preliminary scoring of sleep stages and events according to (AASM) standards. This hands-on involvement ensures accurate data collection for subsequent analysis by sleep specialists. Key responsibilities of sleep technologists encompass maintaining patient safety, such as responding to potential emergencies like seizures or respiratory distress during monitoring, and upholding data quality by identifying and correcting artifacts or inadequate signals in real time. They also adhere strictly to established protocols, including AASM guidelines for study performance and scoring, to guarantee reliable results and compliance with accreditation requirements. These duties demand a blend of technical proficiency and patient-centered care, often involving education on the procedure to alleviate anxiety. Support staff in sleep studies complement technologists by addressing patient comfort and logistical needs. Registered nurses may assist with medical oversight, such as managing any concurrent health issues or providing reassurance during the study, particularly for patients with comorbidities. Aides or technician assistants handle equipment setup, patient positioning, and basic support tasks like facilitating bathroom breaks, ensuring a smooth process without disrupting monitoring. Entry-level training for these roles typically involves an introductory accredited program, such as the requiring 80 hours of instruction, followed by on-the-job experience that can lead to full certification pathways. The certification landscape for sleep technologists has evolved significantly since the 1990s, when the Registered Polysomnographic Technologist (RPSGT) credential, administered by the Board of Registered Polysomnographic Technologists (BRPT), became the primary standard following its initial offerings in 1979. The introduction of the RST in 2011 provided an alternative pathway emphasizing broader competencies, with eligibility often requiring pathways like completion of accredited programs or 6-12 months of supervised clinical experience verified by a sleep specialist. In the 2020s, the ABSM discontinued the RST exam in 2022 while allowing recertification for existing holders until 2032, reflecting shifts toward integrated credentials like RPSGT and the Certification in Clinical Sleep Health (CCSH). While these certifications are prominent in the United States, the RPSGT is recognized internationally, and equivalents exist elsewhere, such as the European Sleep Research Society's (ESRS) Somnologist-Technologist .

Sleep Specialists and Centers

Sleep medicine physicians are medical doctors who specialize in the diagnosis and treatment of sleep disorders, typically completing a one-year fellowship in sleep medicine after residency in fields such as , , or , followed by passing a examination to become diplomates of the American Board of Sleep Medicine (ABSM). These board-certified specialists interpret results from sleep studies, diagnose conditions like or , and prescribe treatments including (CPAP) therapy or behavioral interventions. Accredited sleep centers, certified by the (AASM), must adhere to rigorous standards for diagnostic equipment, such as systems, and staffing requirements, including the presence of qualified physicians and technologists to ensure high-quality patient care. As of 2025, more than 2,500 AASM-accredited sleep centers operate across the , providing standardized environments for conducting in-laboratory and home-based sleep studies. Internationally, similar bodies exist, such as those affiliated with the World Sleep Society or regional organizations like the ESRS, adapting standards to local healthcare systems. Many sleep centers employ multidisciplinary teams to address complex cases, incorporating input from pulmonologists for respiratory-related sleep issues, neurologists for neurological disorders like or , and psychiatrists for conditions involving overlaps such as anxiety-driven sleep disturbances. This collaborative approach enhances comprehensive evaluation and tailored treatment plans. Access to sleep studies is generally referral-based, initiated by providers or other specialists suspecting a , with follow-up consultations often integrating telemedicine options that expanded significantly after 2020 to improve patient convenience and adherence to care. Specialists at accredited centers handle the reporting of study results, providing diagnostic insights and recommendations as detailed in protocols.

Advances and Future Directions

Technological Innovations

Recent advancements in sleep study technology have emphasized portability and wireless connectivity, minimizing the need for cumbersome cables and enabling more comfortable patient experiences. Devices such as DormoTech's DormoVision X, introduced in 2025, utilize a wearable with integrated sensors for EEG, EOG, , SpO2, and monitoring, transmitting data wirelessly via a central unit for real-time streaming to a cloud-based platform. This shift to Bluetooth-enabled and fully wireless sensors, as seen in systems like the Natus HD ambulatory EEG, allows patients to move freely during extended recordings without tethering, supporting both in-lab and home-based (PSG). These innovations reduce setup complexity and patient discomfort, facilitating broader adoption of home testing (HSAT). Improvements in HSAT technology have enhanced diagnostic reliability compared to traditional laboratory PSG, with recent devices achieving substantial agreement in key metrics like apnea-hypopnea index (AHI) severity. For instance, validation studies of peripheral arterial tonometry-based HSATs, such as the NightOwl Mini and Reusable, demonstrate minimal bias in AHI (mean 2.04–2.91 events/h) and oxygen desaturation index (ODI) measurements against PSG, with diagnostic accuracies of 63.8–67.7% overall and low misclassification rates for severe (OSA). By 2023–2025, non-contact smart bed systems incorporating sensors have further improved accuracy to 83.3% for detecting moderate-to-severe OSA (AHI ≥15), with 76.1% and 85.0% specificity, approaching levels that rival full PSG in home settings. These developments, including disposable single-use options, address limitations like signal failures and risks, enabling repeat testing over multiple nights for more robust results. High-resolution ambulatory EEG systems represent a significant leap in extended sleep monitoring outside clinical labs, capturing detailed brain activity over prolonged periods. The HD system, for example, supports up to 96 hours of continuous EEG and recording in a compact, wearable format, compatible with sleep staging software for Level II portable testing. Introduced amid 2025 advancements, these devices incorporate wireless amplifiers and infrared cameras for nighttime use, allowing patients to maintain daily routines while providing lab-quality data on architecture without requiring overnight stays. Such enhances for diagnosing sleep disorders in diverse populations, including those with mobility challenges. Integration of sleep study devices with mobile applications has enabled seamless real-time data syncing and proactive monitoring during home tests. Platforms like Sleeptracker-AI aggregate data from contactless sensors and wearables via cloud APIs, syncing with health apps such as Apple Health for immediate access through no-code dashboards. This facilitates auto-alerts for respiratory events and vital sign anomalies, including oxygen desaturations, allowing customizable notifications to detect disturbances promptly and support remote interventions. By , these app-based ecosystems have streamlined home and HSAT workflows, reducing delays in result reporting and improving patient compliance. Sustainability efforts in sleep study tools have gained traction with the introduction of eco-friendly, disposable sensors in , aiming to mitigate from traditional reusable equipment. Biodegradable textile-based sensors, fabricated from treated with conductive PEDOT:PSS, offer connectivity for monitoring patterns and skin moisture during , demonstrating stability over 4.5 months and full degradation in within 60 days. These single-use innovations, sensitive across 25–91.5% relative ranges, support non-invasive tracking in sleep studies while promoting environmental responsibility through biocompatible, low-waste materials.

AI and Emerging Tools

Artificial intelligence is revolutionizing sleep studies through advanced models that automate and enhance the analysis of polysomnography (PSG) data. A notable example is the Patch Foundational Transformer for Sleep (PFTSleep), a transformer-based AI model developed by researchers at the Icahn School of Medicine at Mount Sinai, which analyzes full-night multichannel sleep data including brain waves (EEG), heart rate variability (HRV), movement, and respiratory signals to classify sleep stages with high accuracy in the largest study of its kind. This approach outperforms prior AI methods by leveraging eight-hour recordings to generate comprehensive sleep summaries, supporting streamlined clinical diagnostics for disorders like obstructive sleep apnea (OSA). Predictive analytics powered by machine learning are enabling early detection of sleep disorders, particularly OSA, using data from wearables. Algorithms such as random forests have demonstrated strong performance in estimating the apnea-hypopnea index (AHI), achieving an area under the curve () of 0.90 for moderate-to-severe OSA screening based on accessible physiological parameters. These models integrate signals from devices like pulse oximeters and accelerometers to predict AHI thresholds (e.g., ≥5 events/hour) with accuracies exceeding 80%, facilitating non-invasive, at-home assessments. Emerging tools are expanding the scope of sleep research beyond traditional . (VR) simulations create controlled sleep environments to study relaxation responses, where exposure to calming virtual scenes reduces anxiety and improves perceived sleep quality compared to neutral conditions. Additionally, AI-integrated genetic studies link single nucleotide polymorphisms (SNPs) to sleep traits by combining wearable-derived digital phenotyping with genome-wide association analyses, identifying variants associated with sleep duration and disorders. As of November 2025, ongoing advancements include the American Academy of Sleep Medicine's guidance on responsible use in , emphasizing ethical deployment to mitigate biases, and Sleep.ai's validation study of models for and using data from 68,000 users across 2.7 million nights. Beacon Biosignals also secured $86 million in funding to expand -driven sleep for brain health insights. Despite these advances, challenges persist in AI application to sleep studies, including biases in training datasets that can skew scoring toward underrepresented demographics, leading to inequities in diagnostic accuracy. Regulatory hurdles also remain, though progress is evident with FDA clearances in 2024 for AI-assisted PSG scorers like EnsoSleep and SleepStage ML, which automate staging from EEG and other signals to enhance clinical workflows.

References

  1. [1]
    Polysomnography (sleep study) - Mayo Clinic
    Jan 1, 2025 · Polysomnography, known as a sleep study, is a test used to diagnose sleep disorders. Polysomnography records your brain waves, the oxygen level in your blood,
  2. [2]
    Sleep Study - StatPearls - NCBI Bookshelf - NIH
    Aug 14, 2023 · Introduction. A polysomnogram (PSG), also known to patients as a sleep study, is an integral component of many sleep evaluations.
  3. [3]
    Sleep Study: Definition and What to Expect - Sleep Foundation
    Jul 23, 2025 · A sleep study is a non-invasive, overnight exam that allows doctors to monitor you while you sleep to see what's happening in your brain and body.What Is a Sleep Study? · Types of Sleep Studies
  4. [4]
    Guide to the Nathaniel Kleitman Papers 1896-2001
    He proposed a regular, 90-minute cycle of rest and activity - in sleep and wakefulness - which he called the basic rest-activity cycle (BRAC). In 1953, Dr.
  5. [5]
    Kleitman, father of sleep research - University of Chicago Chronicle
    Sep 23, 1999 · Later, Kleitman proposed the existence of a basic rest-activity cycle, or BRAC, during both sleep and wakefulness. Kleitman often used himself, ...
  6. [6]
    Regularly Occurring Periods of Eye Motility, and Concomitant ...
    Regularly Occurring Periods of Eye Motility, and Concomitant Phenomena, During Sleep. Eugene Aserinsky and Nathaniel KleitmanAuthors Info & Affiliations.
  7. [7]
    Polysomnography: understanding this technology's past might guide ...
    Hans Berger published the first human electroencephalograph (EEG) recording in 1924 [1]. He used a device called the string galvanometer to record brain waves.
  8. [8]
    History of the Development of Sleep Medicine in the United States
    The first sleep disorders center was established as a narcolepsy clinic at Stanford University in 1964. By 1970 the Stanford group had evolved into a full- ...Missing: authoritative | Show results with:authoritative
  9. [9]
    A Manual of Standardized Terminology, Techniques and Scoring ...
    Mar 1, 2019 · A manual for the standard method of scoring sleep stages. ... Allan Rechtschaffen, Anthony Kales. Publication date: 1968. Topics: R&K, R & K ...
  10. [10]
    EEG Arousals: Scoring Rules and Examples - Oxford Academic
    EEG Arousals: Scoring Rules and Examples, Sleep, Volume 15, Issue 2, 1 March 1992 ... sleep. Issue Section: ASDA Report. Collection: SRS Journals. Article PDF ...
  11. [11]
    AASM Scoring Manual - American Academy of Sleep Medicine
    Apr 9, 2025 · This comprehensive and evolving resource provides rules for scoring sleep stages, arousals, respiratory events during sleep, movements during sleep and cardiac ...Missing: establishment 1992
  12. [12]
    PRO: Sliding into Home: Portable Sleep Testing Is Effective for ...
    Scarce data about home sleep testing in the early 1990s limited the use of the devices on a larger scale. A review was performed by the American Sleep ...
  13. [13]
    Polysomnography - IEEE Pulse
    Sep 23, 2014 · Standardized polysomnography, at least for sleep staging, was established, and a new research arena opened that was ripe for discovery!
  14. [14]
    [PDF] Practice Parameters: Polysomnography Indications (2005)
    The AASM published a clinical practice guideline to make important updates to the recommendations for the diagnosis of obstructive sleep apnea in the 2005 ...
  15. [15]
    [PDF] Practice Parameters for Clinical Use of the Multiple Sleep Latency ...
    The use of MSLT to support a diagnosis of narcolepsy is suspect if TST on the prior night sleep is less than 6 hours. The test should not be performed after ...
  16. [16]
    Sleep apnea - Symptoms and causes - Mayo Clinic
    Apr 6, 2023 · People with central sleep apnea often have severe fatigue, daytime drowsiness and irritability. You might have difficulty concentrating and ...
  17. [17]
    Excessive Daytime Sleepiness - AAFP
    Mar 1, 2009 · The most common causes of excessive daytime sleepiness are sleep deprivation, obstructive sleep apnea, and sedating medications.
  18. [18]
    Apnea-Hypopnea Index (AHI): What It Is & Ranges - Cleveland Clinic
    Feb 21, 2025 · The apnea-hypopnea index (AHI) is the average number of times you stop breathing (apneas) and have shallow breathing events (hypopneas) per hour ...
  19. [19]
    Sleep Architecture in Night Shift Workers Police Officers with ... - NIH
    The aim of this study was to measure the changes in sleep architecture (SA) in police officers who currently have Night shift work (NSW) and OSAHS.
  20. [20]
    Jet lag syndrome: circadian organization, pathophysiology, and ...
    Aug 19, 2010 · Polysomnographic data show that not only does jet lag result in changes of sleep–wake timing, but also in different aspects of sleep ...
  21. [21]
    Circadian Rhythm Sleep Disorders - PMC - NIH
    Abstract. Objective. To review circadian rhythm sleep disorders, including underlying causes, diagnostic considerations, and typical treatments.
  22. [22]
    Sleep and Aging. A Polysomnographic Follow‐Up Study, Some 40 ...
    Mar 18, 2025 · The aim of the present study was to explore age-related sleep alterations in normal subjects whose sleep had been recorded for the first ...
  23. [23]
    Sleep deficiency in spaceflight is associated with degraded ...
    In this study, short sleep duration in-flight was primarily due to a shift in sleep timing that resulted in truncated sleep opportunities; astronauts went to ...Introduction · Methods · Results · Discussion
  24. [24]
    Sleep Patterns of Pilots: An Objective Assessment - PMC - NIH
    May 13, 2023 · We found that pilots and copilots are at risk of irregular sleep patterns, poor sleep efficiency, poor sleep quality, daytime sleepiness, and fatigue.
  25. [25]
    Sleep, time, and space—fatigue and performance deficits in pilots ...
    We conducted a scoping review to synthesize knowledge about sleep, fatigue, and performance in pilots, commercial truck drivers, and astronauts.
  26. [26]
    An International Consensus on the Forensic Assessment of Sleep ...
    An International Consensus on the Forensic Assessment of Sleep-Related Violence and Sexual Behavior in Sleep: If Not Now, When? · Francesca Ingravallo, Ph.D.
  27. [27]
    Sleep and the athlete: narrative review and 2021 expert consensus ...
    Athletic performance is reduced by a night or more without sleep, but the influence on performance of partial sleep restriction over 1–3 nights, a more real- ...Measuring Sleep · The Effect Of Sleep... · Athlete Sleep...<|control11|><|separator|>
  28. [28]
    Informed consent in clinical research: Revisiting few concepts ... - NIH
    Basic ethical principle behind informed consent legalities is to protect the autonomy of human subjects which states that welfare and interests of a subject ...
  29. [29]
    [PDF] Clinical Practice Guideline for Diagnostic Testing for Adult ...
    Introduction: This guideline establishes clinical practice recommendations for the diagnosis of obstructive sleep apnea (OSA) in adults and is intended.
  30. [30]
    Overview of Polysomnography, Parameters Monitored, Staging of ...
    Nov 15, 2023 · The AASM guidance also recommends that PSG or HSAT be used to assess response to treatment with non-PAP interventions, and to reassess sleep- ...
  31. [31]
    Updated protocols available for evaluation of daytime sleepiness ...
    Oct 26, 2021 · The faster the patient falls asleep, the greater the daytime sleepiness. The MSLT is used in the diagnosis of narcolepsy and idiopathic ...
  32. [32]
    Recommended protocols for the Multiple Sleep Latency Test and ...
    Only when the results are clearly diagnostic of narcolepsy after 4 naps with mean latency ≤ 8 minutes and 2 or more SOREMPs have occurred (either because of 2 ...Skip main navigation · BACKGROUND · PROTOCOLS FOR MSLT · DISCUSSION
  33. [33]
    Guidelines for the multiple sleep latency test (MSLT) - PubMed
    Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. ... M A Carskadon, W C Dement, M M Mitler, T Roth, P R Westbrook, S ...Missing: original paper
  34. [34]
    Recommended protocols for the Multiple Sleep Latency Test and ...
    The MSLT is indicated in children and adolescents being evaluated for narcolepsy or IH. It is important for health care providers, patients, and their parent/ ...ABSTRACT · BACKGROUND · PROTOCOL FOR MSLT · DISCUSSION
  35. [35]
    Talking Sleep | The importance of a SOREMP on PSG
    May 31, 2024 · Despite having more treatment options than ever before, narcolepsy remains significantly underdiagnosed. Is there a potential clue on the ...
  36. [36]
    A normative study of the maintenance of wakefulness test (MWT) - NIH
    The maintenance of wakefulness test (MWT) is a daytime polysomnographic procedure which quantifies wake tendency by measuring the ability to remain awake ...Missing: original | Show results with:original
  37. [37]
    Home Sleep Apnea Testing for Obstructive Sleep Apnea - PMC
    The Home Sleep Apnea Testing (HSAT) is now available to diagnose OSA. Understanding the indications and limitations of HSAT is important to avoid misdiagnosis.
  38. [38]
    [PDF] Home Sleep Apnea Testing (HSAT)
    This guideline is intended to provide guidance for the technologist performing and scoring HSAT in accordance with AASM Guidelines (5, 6). The scope of this ...
  39. [39]
    Actigraphy-Based Assessment of Sleep Parameters - PMC - NIH
    Feb 13, 2020 · Actigraphy uses movement data from actigraphs to infer sleep/wake patterns. Special software analyzes this data to estimate sleep parameters.
  40. [40]
    40 years of actigraphy in sleep medicine and current state of the art ...
    Mar 24, 2023 · PSG measures physiological changes during sleep, while wrist actigraphy measures the movement of the distal forearm. Physiology and movement ...Missing: definition | Show results with:definition
  41. [41]
    Use of Actigraphy for the Evaluation of Sleep Disorders and ...
    Our review of the literature identified 46 studies that used actigraphy concurrent with sleep logs and/or PSG in adults with suspected or diagnosed insomnia.
  42. [42]
    Accuracy of 11 Wearable, Nearable, and Airable Consumer Sleep ...
    In particular, the results from Oura Ring 3 and Fitbit Sense 2 in this study showed improved accuracy in sleep stage detection compared to previous studies that ...
  43. [43]
    performance validation of six commercial wrist-worn wearable sleep ...
    The aim of this study is to assess the performance of six different consumer wearable sleep-tracking devices, namely the Fitbit Charge 5, Fitbit Sense, Withings ...
  44. [44]
    Performance of Fitbit Devices as Tools for Assessing Sleep Patterns ...
    Aug 31, 2024 · Overall accuracy of Fitbit is 86.5%–88% [40,42], while it is 81% for light sleep, 49% for deep sleep, and 74% for REM sleep [43]. Go to : Goto ...
  45. [45]
    Use of Actigraphy for the Evaluation of Sleep Disorders and ...
    This clinical practice guideline is intended to update the previously published American Academy of Sleep Medicine (AASM) practice parameters on the use of ...<|separator|>
  46. [46]
    An American Academy of Sleep Medicine Clinical Practice Guideline
    Jul 15, 2018 · We suggest that clinicians use actigraphy in the assessment of pediatric patients with circadian rhythm sleep-wake disorder. (Conditional) 5 ...
  47. [47]
    The role and validity of actigraphy in sleep medicine: An update
    In comparison to PSG, actigraphy has reasonable validity and reliability in assessing sleep-wake patterns in normal individuals with average or good sleep ...
  48. [48]
    A Narrative Review of Wearable Sleep Monitoring - MDPI
    Wearables frequently overestimated light sleep at the expense of deep sleep and REM, largely due to sensor limitations and proprietary staging algorithms, ...
  49. [49]
    FDA clears Apple's sleep apnea detection feature for use - CNBC
    Sep 16, 2024 · The US Food and Drug Administration on Monday cleared Apple 's new sleep apnea detection feature for use, and it is now available to Apple Watch Series 9, ...Missing: screening | Show results with:screening<|separator|>
  50. [50]
    Clinical Sleep Wearables: FDA Approvals Explained - Healify Blog
    One standout is Happy Health's Happy Ring, which gained FDA clearance in June 2025. This device is designed to diagnose obstructive sleep apnea (OSA), insomnia, ...Missing: screening | Show results with:screening
  51. [51]
    Acurable receives FDA clearance for home sleep apnea testing device
    Sep 24, 2024 · Acurable announced it received FDA 510(k) clearance for its AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect ...
  52. [52]
    Sleep Diary: How and Why You Should Keep One - Sleep Foundation
    Jun 20, 2023 · A sleep diary is a simple way to track key details about your sleep habits. It can offer valuable information for your doctor or for ...
  53. [53]
    A new method for measuring daytime sleepiness: the Epworth ...
    This is a simple, self-administered questionnaire which is shown to provide a measurement of the subject's general level of daytime sleepiness.Missing: validation | Show results with:validation
  54. [54]
    Reliability and Efficacy of the Epworth Sleepiness Scale
    Dec 13, 2022 · In the original validation study of Johns, the control subjects had an ESS score of 2–10, and scores ≥11 were only found in the evaluated ...
  55. [55]
    The Pittsburgh Sleep Quality Index: a new instrument for psychiatric ...
    The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval.
  56. [56]
    The Consensus Sleep Diary: Standardizing Prospective Sleep Self ...
    Despite the fact that sleep diaries are widely used in clinical and research settings, with few exceptions, almost no formal reliability and validity data have ...
  57. [57]
    Comparison of the results of the Epworth Sleepiness ... - PubMed - NIH
    ESS scores correlated negatively, but not strongly, with MSLT scores (rho = -0.37, p = 0.0042) and ESS scores of 14 and above predicted a low mean sleep latency ...
  58. [58]
    Correlation of Epworth Sleepiness Scale with multiple sleep latency ...
    The ESS score moderately correlates with MSL and our ROC study supports ESS as a screening strategy for assessing EDS in OSAHS.
  59. [59]
    [PDF] sleep study
    There may be a pre-sleep questionnaire for you to fill out. Then, you can get ready for bed. There won't be any other patients in your room, and there will ...
  60. [60]
    Sleep Study Instructions for Adults - CentraCare
    Do not drink alcohol or take stimulants or sedatives the day of the test. Avoid naps the day of the test. Bathe and shampoo your hair on the day of your test.<|control11|><|separator|>
  61. [61]
    Sleep Study: How It Works and What To Expect
    Oct 4, 2022 · How do you prepare for a sleep study? · Read any instructions from your lab · Bring snacks and medication · Dress comfortably · Avoid hair products ...
  62. [62]
    At-Home Sleep Study: Sleep Apnea Testing in Your Own Bed
    Jul 25, 2025 · A home sleep apnea test (HSAT or HST) is a portable breathing monitor you wear overnight, designed to help diagnose obstructive sleep apnea at home.Missing: components | Show results with:components
  63. [63]
    What to Know About an At-Home Sleep Test | Johns Hopkins Medicine
    Home tests can sometimes be inaccurate: For instance, your sensors might fall off during the night. At a lab, a physician is on-site to monitor you. You might ...Missing: troubleshooting | Show results with:troubleshooting
  64. [64]
    Recommended protocols for the Multiple Sleep Latency Test and ...
    Patients with OSA or other sleep disorders may need an MSLT to evaluate for coexisting narcolepsy or another primary hypersomnia. Sleep-onset REM periods ( ...
  65. [65]
    Physiology, Sleep Stages - StatPearls - NCBI Bookshelf
    EEG recording: beta waves - similar to brain waves during wakefulness. REM is associated with dreaming and is not considered a restful sleep stage. While the ...
  66. [66]
    [PDF] Standard Polysomnography AAST Technical Guideline
    The standard diagnostic PSG requires the monitoring, recording, and evaluation of sleep stages and arousals, respiration, limb movements, snoring, oximetry, ...
  67. [67]
    Technical notes for digital polysomnography recording in sleep ...
    This review is aimed to highlight the technical standards for digital PSG recording and scoring in sleep practice.
  68. [68]
    PSG-Audio, a scored polysomnography dataset with simultaneous ...
    Aug 3, 2021 · A detailed listing of the signals, recorded through the PSG system and the respective sampling frequency for each channel are given in Table 1.Methods · Technical Validation · The Annotated Apnea Related...
  69. [69]
    Polysomnography - an overview | ScienceDirect Topics
    A polysomnogram (PSG) is a procedure that utilizes electroencephalogram, electro-oculogram, electromyogram, electrocardiogram, and pulse oximetry, as well as ...<|control11|><|separator|>
  70. [70]
    Defining Digital Polysomnography - Sleep Review
    A sampling frequency of 200 Hz is adequate, particularly if some data interpretation is performed between samples. Of course, the bandwidth of the signal to be ...
  71. [71]
    Detection of Movement and Lead-Popping Artifacts in ... - MDPI
    Oct 22, 2024 · Artifacts caused by movement or loose leads distort EEG measurements. We developed a method to automatically identify such artifacts in a PSG EEG trace.
  72. [72]
    Comparing Manual and Automatic Artifact Detection in Sleep EEG ...
    Feb 9, 2025 · Sleep EEG data are free from blinking artifacts and less contaminated by movement artifacts than wakeful EEG; however, various artifacts ...
  73. [73]
    [PDF] SCORING SLEEP USING AASM GUIDELINES
    SCORING SLEEP STAGES. This session based on adult scoring rules –. AASM Version ... STAGE N3. • Slow waves in ≥20% (≥6s) of epoch. – 0.5-2 Hz. – ≥75µV in ...<|control11|><|separator|>
  74. [74]
    The pros and cons of using automated sleep scoring in sleep research
    Oct 27, 2023 · Traditionally, this process has relied on manual scoring by human experts, but it is marred by time constraints, and inconsistencies between ...Challenges in Standardizing... · Advantages and... · Key Considerations in...
  75. [75]
    How to interpret the results of a sleep study - PMC - NIH
    Polysomnography (PSG), popularly known as a 'sleep study', has been used for decades to diagnose and evaluate the severity of sleep-disordered breathing. There ...
  76. [76]
    Interrater reliability of sleep stage scoring: a meta-analysis
    In this study, we explored the interrater reliability of manual sleep stage scoring and systematically reviewed the factors affecting reliability.
  77. [77]
    [PDF] Obstructive Sleep Apnea Case Study Facilitator Guide
    What is the AHI/RDI for this patient? Apnea: ≥ 90% reduction in airflow signal (thermistor; breathing cessation) for >10 seconds in duration. Obstructive apnea ...
  78. [78]
    AASM clarifies hypopnea scoring criteria
    Nov 7, 2017 · The AASM continues to recommend scoring hypopneas in adults when there is a ≥ 3% oxygen desaturation from pre-event baseline and/or the event is associated ...
  79. [79]
    Upper Airway Resistance Syndrome - StatPearls - NCBI Bookshelf
    Aug 2, 2025 · Patients with UARS commonly present with snoring, fatigue, daytime tiredness, morning headaches, depressive symptoms, and excessive daytime ...
  80. [80]
    The Scoring of Movements in Sleep
    Table 3a—ICSD-212 Criteria for the Diagnosis of PLMD. A. Polysomnography demonstrates repetitive highly stereotyped limb movements that are i. 0.5 to five ...
  81. [81]
    [PDF] Obstructive Sleep Apnea
    • Mild OSA: AHI of 5-15. Involuntary sleepiness during activities that require little attention, such as watching TV or reading. • Moderate OSA: AHI of 15-30.
  82. [82]
    Frequency and Accuracy of “RERA” and “RDI” Terms in the Journal ...
    The respiratory disturbance index (RDI) was implicitly defined as all breathing events (apneas+hypopneas+RERAs) divided by total sleep time. However, AASM ...Skip main navigation · INTRODUCTION · DISCLOSURE STATEMENT
  83. [83]
    Polysomnographic scoring of sleep bruxism events is accurate even ...
    Aug 12, 2019 · This study shows that compared to video-audio-PSG (gold standard) scoring based on PSG with audio alone or frontal EEG alone with audio are acceptable for ...
  84. [84]
    Moving toward standardization: physician reporting of sleep studies
    The goal of this document is to offer recommendations for structured reporting of sleep studies. We offer a practical, complete, and relevant document.
  85. [85]
    Sleep Study: What It Is, What To Expect, Types & Results
    A common recommendation for a sleep study is to bathe or shower beforehand. However, you should avoid using creams, lotions, hair care products, etc., afterward ...
  86. [86]
    CPAP Titration Sleep Study | Sleep Foundation
    Jul 25, 2025 · In some cases, good or adequate results are followed up with an at-home titration using an APAP. If your results are determined to be inadequate ...What Is a CPAP Titration Sleep... · What to Expect During a CPAP...
  87. [87]
    Interrater reliability of sleep stage scoring: a meta-analysis - PMC
    We evaluated the interrater reliabilities of manual polysomnography sleep stage scoring. We included all studies that employed Rechtschaffen and Kales rules ...
  88. [88]
    Overview of the hypnodensity approach to scoring sleep ... - Frontiers
    Hypnodensity based on multiple manual scorings. As discussed recently by Penzel (2022), error rates of 15% or more are usually accepted for sleep stage scoring.
  89. [89]
    An American Academy of Sleep Medicine Clinical Practice Guideline
    This guideline establishes clinical practice recommendations for the diagnosis of obstructive sleep apnea (OSA) in adults.
  90. [90]
    LCD - Polysomnography and Other Sleep Studies (L34040) - CMS
    The diagnosis of narcolepsy is usually confirmed by an overnight sleep study (polysomnography) followed by a multiple sleep latency test (MSLT). · MSLT is the ...
  91. [91]
    The impact of bariatric surgery on breathing-related ... - Frontiers
    We conducted this systematic review and meta-analysis (SRMA) to evaluate the impact of bariatric surgery on obstructive sleep apnea (OSA)<|control11|><|separator|>
  92. [92]
    Use of polysomnography and home sleep apnea tests for the ...
    This paper provides guidance from the American Academy of Sleep Medicine (AASM) regarding the use of polysomnography (PSG) and home sleep apnea tests (HSATs)Missing: protocol | Show results with:protocol
  93. [93]
    PEDIATRIC POLYSOMNOGRAPHY - PMC - PubMed Central - NIH
    Pediatric polysomnography is indicated to evaluate infants and children with suspected pathologic central apnea, periodic breathing or central hypoventilation.
  94. [94]
    Sleep in the Elderly - PMC - NIH
    As part of the natural aging process, sleep becomes more fragmented and lighter with an increase in the number of EEG arousals and awakenings which result in ...
  95. [95]
    Effects of continuous positive airway pressure on cardiac events and ...
    02). Similarly, CPAP significantly reduced the risk of all-cause and cardiovascular death by 23% (RR 0.77, 95% CI 0.60 to 0.99; P = . 04; I2 = 0%).Missing: percentage | Show results with:percentage
  96. [96]
    Treatment for sleep apnoea is good for the heart in some patients ...
    Aug 6, 2025 · For these patients, CPAP lowered cardiovascular risk by 24% in high-risk OSA but increased cardiovascular risks in the other patients by 30%. Dr ...
  97. [97]
    Sleep to Remember - PMC - NIH
    Jan 18, 2017 · There is some evidence that the REM stage of sleep is involved in the consolidation of procedural memory. Procedural memory can best be ...
  98. [98]
    Effects of Slow-Wave Activity on Mood Disturbance in Major ...
    Studies have demonstrated that decreases in slow-wave activity (SWA) predict decreases in depressive symptoms in those with major depressive disorder (MDD).
  99. [99]
    Sleep Disorders and Daytime Sleepiness in Children with Attention ...
    We conclude that children with ADHD demonstrate objective daytime somnolence, which may explain the beneficial effects of treatment with stimulant medications.
  100. [100]
    What Should Be the Focus of Treatment When Insomnia Disorder Is ...
    Mar 2, 2023 · Other studies have shown that insomnia is often comorbid with depression or anxiety with rates of comorbidity near 50% [8]. When patients ...
  101. [101]
    One night of sleep deprivation impairs executive function but does ...
    The present study showed that one night of sleep deprivation resulted in executive function deterioration but did not modify motor control or maximal effort.
  102. [102]
  103. [103]
    Cognitive Behavioral Therapy for Insomnia (CBT-I): A Primer - PMC
    CBT-I is a multi-component treatment for insomnia that targets difficulties with initiating and/or maintaining sleep and is delivered over the course of six to ...
  104. [104]
    CBT-I Coach: A Description and Clinician Perceptions of a Mobile ...
    CBT-I Coach promotes daily completion and accuracy of sleep diaries and uses the data to automatically calculate derived sleep variables. Users are prompted to ...
  105. [105]
    RST Certification - ABSM - American Board of Sleep Medicine
    Apr 5, 2023 · The American Board of Sleep Medicine discontinued the Registered Sleep Technologist certification examination in 2022.
  106. [106]
    Technologist Description - American Academy of Sleep Medicine
    Jul 30, 2024 · A sleep technologist works under the general supervision of the medical director ordesignee to provide comprehensive evaluation and treatment of sleep ...
  107. [107]
    [PDF] UW HEALTH JOB DESCRIPTION - Sleep Technologist Assistant
    Monitor patient safety and adhere to patient safety protocols. 6. Adhere to AASM scoring parameters. 7. Identify artifact, inadequate signals, and equipment ...
  108. [108]
    An Overview of Staff and Personnel That Work in a Sleep Clinic
    Jun 11, 2022 · Here's a quick overview of the different healthcare workers you'll likely meet and interact with as part of your sleep study.
  109. [109]
    About the RPSGT Credential - BRPT
    The Registered Polysomnographic Technologist (RPSGT) is a mid-level, internationally recognized credential representing the highest certification in the field.Missing: 1990s 2020s
  110. [110]
    [PDF] CANDIDATE HANDBOOK FOR THE SLEEP TECHNOLOGIST ...
    The knowledge needed to be a competent Sleep Technologist typically requires a year of comprehensive training. This may include full-time training at a ...
  111. [111]
    ABSM to discontinue Registered Sleep Technologist exam
    Mar 7, 2022 · The American Board of Sleep Medicine announced that it will discontinue the Registered Sleep Technologist certification examination.
  112. [112]
    Career Pathway | Sleep Medicine Specialty | AASM
    Sep 17, 2021 · Learn about the pathway to become a board-certified sleep medicine physician. Find information for medical students, residents and fellows.
  113. [113]
    American Board of Sleep Medicine (ABSM)
    Jul 14, 2023 · Registered Sleep Technologist credential holders must recertify every five years. The American Board of Sleep Medicine will administer RST ...RST Certification · Verify Credential · Behavioral Sleep Medicine · About
  114. [114]
    Apply for American Academy of Sleep Medicine Accreditation
    AASM accreditation is the gold standard by which the medical community and the public can evaluate sleep medicine services.Accreditation Verification · Choose AASM Accreditation · Apply or Renew
  115. [115]
  116. [116]
    Our Physicians and Experts | Johns Hopkins Medicine
    A multi-disciplinary team of sleep experts with training in pulmonary, neurology, internal medicine, otolaryngology, anesthesiology, psychiatry, and behavioral ...
  117. [117]
    Telemedicine improves access to high-quality sleep care - AASM
    Aug 6, 2024 · The paper shares new evidence that telemedicine is effective in the diagnosis and management of obstructive sleep apnea and improves adherence ...Missing: integration | Show results with:integration
  118. [118]
    Maintenance of Certification (MOC) for Sleep Medicine Physicians
    Jun 17, 2024 · Each exam contains multiple-choice, case-based questions written by board-certified sleep medicine physicians. Approved by Leading Boards.
  119. [119]
    DormoTech unveils FDA-cleared wireless sleep diagnostics platform
    Jun 18, 2025 · DormoTech introduced DormoVision X, a wireless, AI-powered home sleep testing platform, during the SLEEP 2025 annual meeting in Seattle.Missing: innovations Bluetooth 2023-2025
  120. [120]
    Trex HD Monitoring Ambulatory EEG System - Natus
    Real-time ambulatory EEG recording in a compact, portable, wearable device. · Fully wireless solution designed specifically for patient comfort · With convenient, ...
  121. [121]
    Validation of a single-use and reusable home sleep apnea test ...
    Assessing the validity of results of new HSAT devices compared to PSG is not as straightforward as obtaining correlation coefficients, even though they are ...
  122. [122]
    Validating a smart bed against polysomnography for sleep apnea ...
    Jul 2, 2025 · The algorithm achieved an accuracy of 83.3% in identifying individuals with moderate-to-severe apnea (AHI ≥ 15), demonstrating a sensitivity of ...Methods · Results · Apneic Event Classification...
  123. [123]
  124. [124]
    Eco-Friendly Textile-Based Wearable Humidity Sensor with ...
    Textile-based wearable humidity sensors are of great interest for human healthcare monitoring as they can provide critical human-physiology information.
  125. [125]
    New AI Model Analyzes Full Night of Sleep With High ... - Mount Sinai
    Mar 17, 2025 · A transformer-based AI model analyzes eight-hour sleep signals from brain, movement, cardiac, and respiratory data to generate summaries.Missing: EEG HRV
  126. [126]
    A foundational transformer leveraging full night, multichannel sleep ...
    Aug 14, 2025 · A foundational transformer leveraging full night, multichannel sleep study data accurately classifies sleep stages. Sleep. 2025 Aug 14;48(8): ...Missing: EEG HRV
  127. [127]
    A foundational transformer leveraging full night, multichannel sleep ...
    Aug 5, 2024 · A foundational transformer model (PFTSleep) using 8-hour, multichannel sleep data improves sleep stage classification over existing AI methods.
  128. [128]
    Advances in Machine Learning Prediction Models for the Screening ...
    AHI ≥ 5:ACC:81.2%AUC:0.90AHI ≥ 15:ACC:90.9%AUC:0.96AHI ≥ 30 ... random forest machine learning models for daytime diagnosis of obstructive sleep apnea.
  129. [129]
    Enhanced machine learning approaches for OSA patient screening
    Aug 26, 2024 · This study aimed to develop and evaluate OSA prediction models using simple and accessible parameters, combined with multiple machine learning algorithms.
  130. [130]
    (PDF) Wearable Sensors and Artificial Intelligence for sleep apnea ...
    Dec 2, 2024 · The integration of wearable devices and artificial intelligence technologies has revolutionized the treatment and diagnosis of sleep apnea.
  131. [131]
    the potential of using virtual reality at bedtime to facilitate sleep - NIH
    Relaxing environments elicited greater perceived quietness and happiness and reduced anger, sadness, anxiety, and negative affect than neutral VR; opposite ...
  132. [132]
    Genome-wide association analysis of composite sleep health scores ...
    Feb 3, 2024 · Recent genome-wide association studies (GWASs) of several individual sleep traits have identified hundreds of genetic loci, ...
  133. [133]
    Beyond accuracy: a framework for evaluating algorithmic bias and ...
    Jul 1, 2025 · Recent advancements in artificial intelligence (AI) have significantly improved sleep-scoring algorithms, bringing their performance close ...
  134. [134]
    Benefits and Challenges of AI in Sleep Medicine - InventUM
    Jul 8, 2024 · The authors emphasize developing AI algorithms free of bias, which depends in large part on the data upon which it is trained and deployed.
  135. [135]
    EnsoData receives FDA 510(k) clearance of new EnsoSleep features
    Sep 24, 2024 · EnsoData announced its FDA 510(k) clearance of new capabilities and enhancements to EnsoSleep, an artificial intelligence (AI)-assisted sleep scoring solution.
  136. [136]
    Beacon Biosignals receives FDA clearance for sleep staging software
    Sep 24, 2024 · On March 27, 2024, Beacon Biosignals announced it received FDA 510(k) clearance for SleepStage ML, its artificial intelligence (AI)/machine ...